The utility of the Sysmex XE-2100 analyzer's NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes

International Journal of Laboratory Hematology

Volumn 32, Issue 3, 2010, Pages 360-366

  Furundarena, J R ^a   Araiz, M ^a   Uranga, M ^a   Sainz, M R ^a   Agirre, A ^a   Trassorras, M ^a   Uresandi, N ^a   Montes, M C ^a   Argoitia, N ^a  

^a HOSPITAL DONOSTIA   (Spain)

Author keywords

Chronic myelomonocytic leukemia; Myelodysplastic syndromes; NEUT X; NEUT Y; Neutrophil dysplasia

Indexed keywords

ANALYZER; ANEMIA; ARTICLE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; COMORBIDITY; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DYSPLASIA; HEMATOLOGICAL PARAMETERS; HUMAN; LEUKOPENIA; MYELODYSPLASTIC SYNDROME; NEUTROPHIL DYSPLASIA; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; CHEMISTRY; CYTOLOGY; FEMALE; GRANULOCYTE; MALE; MYELODYSPLASTIC SYNDROMES; NEUTROPHIL; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STANDARD;

ANEMIA; FEMALE; GRANULOCYTES; HUMANS; LEUKOPENIA; MALE; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; REFERENCE STANDARDS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 77953562454     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01194.x     Document Type: Article

References (7)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R. & Sultan C. (1982) Proposals for the classification of the myelodysplastic syndromes. French-American-British (FAB) Cooperative Group. British Journal Haematology 51, 189-199.
2. Brunning R.D., Head D., Bennett J.M., Vardiman J.W., Flandrin G., Harris N.L. & Matutes E. (2001) Myelodisplastic syndromes. In: Tumours of Haematopoietic and Lymphoid Tissues (eds E.S. Jaffe, N.L. Harris, H. Stein & J.W. Verdi-man), pp. 63-67. IARC Press, Lyon.
3. Cymbalista F. (2005) Usefulness of XE-2100 structural parameters in the diagnosis of myelodysplastic syndrome. Proceedings of the Sysmex European Symposium Austria, pp. 26-32. Sysmex Europe GMBH, Germany.
4. Cymbalista F. (2008) Usefulness of NEUT-X determination in routine diagnostic procedures: application to myelodys-plastic syndromes. Sysmex Luncheon Symposium. ISLH Sydney.
5. Linssen J., Aderhold S., Nierhaus A., Frings D., Kaltschmidt C. & Zänker K. (2008) Automation and validation of a rapid method to assess neutrophil and monocyte activation by routine fluore-scence flow cytometry in vitro. Cytometry Part B (Clinical Cytometry) 74B, 295-309.
6. Schillinger F. (2009) Interest of NEUT-X in MDS/MPD diagnosis and chronic monocytosis. Sysmex 5th European Haematology Symposium, Turkey; May 14-15. pp. 57. Sysmex Europe GMBH, Germany.
7. Tkachuk D.C., Chun K. & Hisrschmann J.V., eds (2007) Myelodysplastic syndromes. In: Wintrobe's Atlas of Clinical Hematology, 1st edn, Lippincott Willians & Wilkins, Philadelphia, PA. 94-104.